calendar
69 catalysts · 69 phase readout · 24 8k filing · 4 earnings
next 91 dayslessmore
MonWedFri
69 catalysts · 69 phase readout · 24 8k filing · 4 earnings
Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia
Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Chronic Intestinal Failure, Intestinal Failure, Home Parenteral Nutrition
Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Cancer Pain, Neoplasm-Related Pain
Sponsor: Dr. Mark Mulder. Phase: . Conditions: Cancer-related Pain, Pain Assessment, Artificial Intelligence (AI), Oncology, Oncology Pain, Database, Facial Expression, Voice, Cancer
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Postoperative Pulmonary Complications (PPCs), Abdominal Surgeries, Postoperative Pain Management
Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Gynecologic Cancer, Urologic Cancer, Breast Cancer
Sponsor: French Africa Pediatric Oncology Group. Phase: . Conditions: Staging, Therapeutic Recommendations
Sponsor: Centre Hospitalier Universitaire Dijon. Phase: PHASE3. Conditions: Elective Surgery for Any Digestive Cancer
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Neoplasms, Postoperative Complications, Perioperative/Postoperative Complications, Intensive Care Units
Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE3. Conditions: Head and Neck Cancer
Sponsor: Azienda USL Reggio Emilia - IRCCS. Phase: NA. Conditions: Professional Quality of Life, Palliative Care, Oncology
Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Head and Neck Cancer
Sponsor: Société des Produits Nestlé (SPN). Phase: NA. Conditions: Cerebral Palsy (CP), Oncology
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Breast Cancer, Mastectomy, Postoperative Pain, Analgesic Use
Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Multiple Myeloma, Lymphoma, Non-Hodgkin, Leukemia-Lymphoma, Adult T-Cell, Hodgkin Disease, Non-Small Cell Lung Cancer
Sponsor: Radionetics Oncology. Phase: PHASE1. Conditions: Locoregionally Recurrent Hormone-receptor Positive Breast Cancer, Metastatic Hormone Receptor Positive Breast Cancer
Sponsor: Loxo Oncology, Inc.. Phase: PHASE3. Conditions: Lymphoma, Mantle-Cell
Sponsor: University of Salamanca. Phase: NA. Conditions: Oncology, Chemotherapy-Induced Peripheral Neuropathy
Sponsor: Johannes Gutenberg University Mainz. Phase: NA. Conditions: Pediatric Oncology
Sponsor: NRG Oncology. Phase: PHASE2. Conditions: Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8, Stage IV Major Salivary Gland Cancer AJCC v8, Unresectable Salivary Gland Carcinoma
Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neuroblastoma
Sponsor: Nested Therapeutics, Inc. Phase: PHASE1. Conditions: Oncology, MEK Mutation, RAF Gene Mutation, Ras (KRAS or NRAS) Gene Mutation, Melanoma, NSCLC, Glioma, Solid Tumor, Adult, MAPK Pathway Gene Mutation
Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Cancer
Sponsor: Institute of Oncology Ljubljana. Phase: PHASE4. Conditions: Breast Cancer, Adherence, Medication
Sponsor: NRG Oncology. Phase: PHASE1. Conditions: Advanced Esophageal Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma, Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage IIB Esophageal Adenocarcinoma AJCC v8, Clinical Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical Stage III Esophageal Adenocarcinoma AJCC v8, Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage II Esophageal Adenocarcinoma AJCC v8, Pathologic Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIB Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage III Esophageal Adenocarcinoma AJCC v8, Pathologic Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIIA Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Pathologic Stage IIIB Esophageal Adenocarcinoma AJCC v8, Pathologic Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage II Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage III Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIA Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIB Esophageal Adenocarcinoma AJCC v8, Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8, Unresectable Gastroesophageal Junction Adenocarcinoma, Squamous Cell Carcinoma, Squamous Cell Cancer
Sponsor: Spanish Oncology Genito-Urinary Group. Phase: . Conditions: Genitourinary Cancers
Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE2. Conditions: Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Unresectable Dedifferentiated Liposarcoma
Sponsor: Singapore General Hospital. Phase: NA. Conditions: Advanced Cancer
Sponsor: Exelixis. Phase: PHASE1. Conditions: Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor, Hepatocellular Carcinoma (HCC), Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC), Head and Neck Squamous Cell Carcinoma (HNSCC), Clear Cell Renal Cell Carcinoma (ccRCC), Non-Clear Cell Renal Cell Carcinoma (nccRCC)
Sponsor: Yaou Liu. Phase: . Conditions: Brain (Nervous System) Cancers, Glioma, Brain Tumor
Sponsor: University of Manitoba. Phase: PHASE1. Conditions: Childhood Cancer, Cancer
Sponsor: European Institute of Oncology. Phase: . Conditions: Cancer Related Cognitive Impairment, Breast Cancer Survivors
Sponsor: Xinjiang Medical University. Phase: NA. Conditions: Cancer Therapy-Related Cardiac Dysfunction, Cardio-oncology, Cancer Survivorship, Cardiovascular Risk, Heart Failure
Sponsor: Institute of Oncology Ljubljana. Phase: NA. Conditions: Liver Neoplasms, Liver Metastases, Pancreatic Neoplasms
Sponsor: Pfizer. Phase: . Conditions: Breast Cancer
Sponsor: Children's Oncology Group. Phase: . Conditions: Adult Cystic Nephroma, Anaplastic Kidney Wilms Tumor, Angiolipoma, Cellular Congenital Mesoblastic Nephroma, Classic Congenital Mesoblastic Nephroma, Clear Cell Sarcoma of the Kidney, Congenital Mesoblastic Nephroma, Cystic Partially Differentiated Kidney Nephroblastoma, Diffuse Hyperplastic Perilobar Nephroblastomatosis, Extrarenal Rhabdoid Tumor, Kidney Medullary Carcinoma, Kidney Neoplasm, Kidney Oncocytoma, Kidney Wilms Tumor, Metanephric Adenofibroma, Metanephric Adenoma, Metanephric Stromal Tumor, Metanephric Tumor, Mixed Congenital Mesoblastic Nephroma, Ossifying Renal Tumor of Infancy, Papillary Renal Cell Carcinoma, Renal Cell Carcinoma, Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions, Rhabdoid Tumor of the Kidney, Wilms Tumor
Sponsor: Stanford University. Phase: NA. Conditions: Colorectal Cancer
Sponsor: Technical University of Madrid. Phase: NA. Conditions: Cardiovascular Diseases, Endocrinology, Inmunology, Neurology, Oncology, Rare Diseases
Sponsor: Children's Oncology Group. Phase: PHASE3. Conditions: Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma, Metastatic Embryonal Rhabdomyosarcoma, Metastatic Rhabdomyosarcoma, Solid Alveolar Rhabdomyosarcoma, Spindle Cell Rhabdomyosarcoma, Spindle Cell/Sclerosing Rhabdomyosarcoma
Sponsor: Nanfang Hospital, Southern Medical University. Phase: . Conditions: Digestive Oncology
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics). Phase: PHASE1. Conditions: Solid Tumor, Adult, Metastatic Breast Cancer, Advanced Breast Cancer, HER2 Mutation-Related Tumors, HER2-positive Metastatic Breast Cancer, KRAS Mutant Metastatic Colorectal Cancer, Metastatic Lung Cancer, Metastatic Colorectal Cancer, Advanced Lung Cancer, HR-positive, HER2-negative Advanced Breast Cancer, HER2-positive Advanced Breast Cancer
Sponsor: NRG Oncology. Phase: PHASE3. Conditions: Prostate Adenocarcinoma, Stage I Prostate Adenocarcinoma AJCC v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage III Prostate Adenocarcinoma AJCC v7
Sponsor: Carl Ola Landgren, MD, PhD. Phase: PHASE2. Conditions: Multiple Myeloma
Sponsor: Istituto Ortopedico Rizzoli. Phase: . Conditions: Spine Tumor, Vertebral Metastasis, Vertebral Column Mass
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Gastrointestinal Cancer, Sarcopenia, Neuromuscular Blockade
Sponsor: European Institute of Oncology. Phase: NA. Conditions: Endoscopic Video-assisted Nipple-sparing Mastectomy, Breast Surgery, Breast Cancer
Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE3. Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Radiation Oncology
Sponsor: University of Saskatchewan. Phase: NA. Conditions: Exercise Oncology